ClearPoint Neuro, Inc. (CLPT) Free cash flow 2017–2025
ClearPoint Neuro, Inc. (CLPT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.5MFY2025 · since FY2017: -$5.8M → -$9.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.5M | +32.3% |
| FY2024 | -$14.0M | +17.1% |
| FY2023 | -$16.9M | -30.4% |
| FY2022 | -$12.9M | -62.4% |
| FY2021 | -$8.0M | -175.9% |
| FY2020 | -$2.9M | +37.7% |
| FY2019 | -$4.6M | +23.4% |
| FY2018 | -$6.1M | -3.6% |
| FY2017 | -$5.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Net marginCLPT Gross profitCLPT Gross marginCLPT Operating incomeCLPT Operating marginCLPT Operating cash flowCLPT Capital expendituresCLPT Return on equityCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Total liabilitiesCLPT Shareholders’ equityCLPT overview →